Form 4 for BRTX BioRestorative Therapies, Inc.
Accepted 2024-03-20 00:00:00 ET · period of report 2024-03-18 · accession 0001021771-24-000077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-20 | 2024-03-18 | BRTX | ALSTODT LANCE | Pres, CEO, COB, Dir | F - Tax | $1.39 | -17.6K | 171.9K | -9% | -$24.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-18 | F | D | 17,633 | $1.39 | 171,872 | D | — | — |